Inflammation in Neurodegenerative Disease and Injury

Encyclopedia of Neuroscience

Volumn , Issue , 2009, Pages 131-136

  Tansey, M G ^a   Kernie, S G ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Acute phase response; Anti inflammatory drug; Astrocytes; Chemokines; Complement; Corticosteroids; Cytokines; Inflammation; Interleukins; Microglia; Minocycline; Neurodegeneration; Neuroinflammation; Oxidative stress; Parkinson's disease (PD); Proteinopathy; Transforming growth factor (TGF ); Traumatic brain injury (TBI); Tumor necrosis factor (TNF )

Indexed keywords

EID: 84882896541     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008045046-9.00504-0     Document Type: Chapter

References (22)

1. Arai H., Furuya T., Mizuno Y., et al. Inflammation and infection in Parkinson's disease. Histology and Histopathology 2006, 21:673-678.
2. Block M.L., Hong J.S. Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism. Progress in Neurobiology 2005, 76:77-98.
3. Chen H., Zhang S.M., Hernan M.A., et al. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Archives of Neurology 2003, 60:1059-1064.
4. Chen H., Jacobs E., Schwarzschild M.A., et al. Nonsteroidal antiinflammatory drug use and the risk of Parkinson's disease. Annals of Neurology 2005, 59:988-989.
5. Edwards P., Arango M., Balica L., et al. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet 2005, 365:1957-1959.
6. Hald A., Lotharius J. Oxidative stress and inflammation in Parkinson's disease: Is there a causal linkΑ. Experimental Neurology 2005, 193:279-290.
7. Hirsch E.C., Hunot S., Hartmann A. Neuroinflammatory processes in Parkinson's disease. Parkinsonism &Related Disorders 2005, 11(supplement 1):S9-S15.
8. Jellinger K.A. Traumatic brain injury as a risk factor for Alzheimer's disease. Journal of Neurology, Neurosurgery &Psychiatry 2004, 75:511-512.
9. McGeer P.L., Itagaki S., Boyes B.E., et al. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988, 38:1285-1291.
10. McGeer P.L., Schwab C., Parent A., et al. Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Annals of Neurology 2003, 54:599-604.
11. Minghetti L. Role of inflammation in neurodegenerative diseases. Current Opinion in Neurology 2005, 18:315-321.
12. Mrak R.E., Griffin W.S. Glia and their cytokines in progression of neurodegeneration. Neurobiology of Aging 2005, 26:349-354.
13. Sanchez-Pernaute R., Ferree A., Cooper O., et al. Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease. Journal of Neuroinflammation 2004, 1:6.
14. Wersinger C., Sidhu A. Inflammation and Parkinson's disease. Current Drug Targets - Inflammation &Allergy 2002, 1:221-242.
15. Wersinger C., Sidhu A.- American Parkinson Disease Association Inc. http://www.apdaparkinson.org.
16. Wersinger C., Sidhu A. - Database for Parkinson's disease genetic association studies, Massachusetts General Hospital/Harvard Medical School, The Michael J. Fox Foundation and Alzheimer Research Forum. http://www.pdgene.org.
17. Wersinger C., Sidhu A. - Medical, legal, and informational resources for persons dealing with traumatic brain injury. http://www.braininjury.com.
18. Wersinger C., Sidhu A. - National Parkinson Foundation. http://www.parkinson.org.
19. Wersinger C., Sidhu A.- Parkinson's Disease Foundation. http://www.pdf.org.
20. Wersinger C., Sidhu A.- The Brain Trauma Foundation. http://www.braintrauma.org.
21. Wersinger C., Sidhu A. - The Michael J. Fox Foundation for Parkinson's Research. http://www.michaeljfox.org.
22. Wersinger C., Sidhu A. - World Parkinson Congress. http://www.worldpdcongress.org.